Liver Failure, Acute
18
0
0
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.6%
1 terminated out of 18 trials
87.5%
+1.0% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (18)
Comparison of Two Liver Dialysis Systems : MARS Versus SPAD in Severe Liver Failure
Correlation of Blood Gene Expression (TruGraf Liver) With Liver Biopsy in Pediatric Liver Transplant Recipients
Endoscopic Ultrasound Guided Liver Biopsy and Portal Pressure Registry
Validation of a Prognostic Score for Steroid Therapy Response in Acute Severe Autoimmune Hepatitis
Efficacy of L-ornithine L-aspartate and Therapeutic Plasma Exchange Versus Plasma Exchange Alone in Lowering Ammonia and Improving Outcomes in Pediatric Acute Liver Failure.
Citrate Pharmacokinetics in Critically Ill Liver Failure Patients Receiving CRRT
HEpatic Regeneration With COupled Plasma Filtration and Adsorption for Liver Extracorporeal Detoxification
Perioperative Lactate Kinetics in Patient Undergoing Major Liver Surgery
Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant
Hepatocyte Transplantation for Acute Decompensated Liver Failure
Safety and Efficacy of hiHep Bioartificial Liver Support System to Treat Acute Liver Failure
Acetaminophen in Combination With N-Acetylcysteine (NAC) Versus Placebo in Treating Fever
Neuromonitoring of Hepatic Encephalopathy
Use of N-Acetylcysteine During Liver Procurement
Right Hepatectomy in Patients Beyond 70 Years Old
Granulocyte Colony Stimulating Factor (G-CSF) in Acute Liver Failure and Alcoholic Hepatitis
Efficacy & Safety of ALF-5755 in Patients With Nonacetaminophen Severe Acute Hepatitis & Early Stage Acute Liver Failure
Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant Hepatic Failure